Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Lun Yan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal for Immunotherapy of Cancer|October 2, 2021
Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironmentWan-Lun Yan, Chiao-Chieh Wu, Kuan-Yin Shen, et al.
Immunotherapy|March 18, 2017
Recent progress in GM-CSF-based cancer immunotherapyWan-Lun Yan, Kuan-Yin Shen, Chun-Yuan Tien, et al.
Oncoimmunology|May 4, 2016
Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapyLi-Sheng Chang, Wan-Lun Yan, Yu-Wen Chang, et al.
Cancers|April 2, 2020
Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic CellsKuan-Yin Shen, Hsin-Yu Liu, Wan-Lun Yan, et al.
Journal of Cell Science|October 3, 2015
NRIP is newly identified as a Z-disc protein, activating calmodulin signaling for skeletal muscle contraction and regenerationHsin-Hsiung Chen, Wen-Pin Chen, Wan-Lun Yan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|October 2, 2021
Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironmentWan-Lun Yan, Chiao-Chieh Wu, Kuan-Yin Shen, et al.
Immunotherapy|March 18, 2017
Recent progress in GM-CSF-based cancer immunotherapyWan-Lun Yan, Kuan-Yin Shen, Chun-Yuan Tien, et al.
Oncoimmunology|May 4, 2016
Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapyLi-Sheng Chang, Wan-Lun Yan, Yu-Wen Chang, et al.
Cancers|April 2, 2020
Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic CellsKuan-Yin Shen, Hsin-Yu Liu, Wan-Lun Yan, et al.
Journal of Cell Science|October 3, 2015
NRIP is newly identified as a Z-disc protein, activating calmodulin signaling for skeletal muscle contraction and regenerationHsin-Hsiung Chen, Wen-Pin Chen, Wan-Lun Yan, et al.
Pageof 1